Higgins Jack

Reported to SECin USFilings at 1 company

No score on this page, by design. These filings come from the American register (SEC). We show them as facts, with what the share price did since each filing and since each trade; our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings by this filer, out of 6. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are this filer’s key figures and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first. Reported is the day the filing reached the regulator, usually a few days after the trade itself.

5 of 6
Reported insider transactions
CompanyTypeValueReportedCompanyValueTypeSharesReported
Immunome Inc.Chief Scientific OfficerOption exercisenothing paid18,000 sharesSep 15, 2026Immunome Inc.Chief Scientific Officernothing paidExercise · Sep 15Option exercise18,000Sep 15, 2026
Immunome Inc.Chief Scientific OfficerGiftnothing paid8,800 sharesSep 15, 2026Immunome Inc.Chief Scientific Officernothing paidGift · Sep 15Gift8,800Sep 15, 2026
Immunome Inc.Chief Scientific OfficerOpen-market sell$334,22413,200 sharesSep 15, 2026Immunome Inc.Chief Scientific Officer$334,224Sell · Sep 15Open-market sell13,200Sep 15, 2026
Immunome Inc.Chief Scientific OfficerOption exercise$24,30018,000 sharesSep 15, 2026Immunome Inc.Chief Scientific Officer$24,300Exercise · Sep 15Option exercise18,000Sep 15, 2026
Immunome Inc.Chief Scientific OfficerAwardnothing paid76,500 sharesJul 27, 2026Immunome Inc.Chief Scientific Officernothing paidAward · Jul 27Award76,500Jul 27, 2026